Drug Profile
Research programme: hepatitis C virus non-structural protein modulators - Valneva
Alternative Names: CVVS 732; CVVS-59911; VLS 732; VLS-702; VLS-801Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Vivalis
- Developer Valneva
- Class Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein modulators; Hepatitis C virus NS3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Hepatitis C